Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Apr;61(4):639–643. doi: 10.1038/bjc.1990.142

Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.

S D Fosså 1, F Langmark 1, N Aass 1, A Andersen 1, R Lothe 1, A L Børresen 1
PMCID: PMC1971362  PMID: 2109999

Abstract

The incidence of a new primary non-germ cell malignancy was determined in 876 patients with testicular cancer treated at the Norwegian Radium Hospital from 1956 to 1977. Sixty-five patients developed a second cancer leading to a statistically significant increased relative risk (RR = 1.58), especially if extended radiotherapy had been given (RR = 4.13). The excess risks of developing lung cancer and malignant melanoma were 2.03 and 3.89, respectively. Increased RR for these two cancer types were seen both after extended radiotherapy and after radiotherapy combined with chemotherapy. Studies of the time between treatment and secondary lung cancer indicated that the development of the new lung cancer could be partly treatment related, whereas the raised incidence of malignant melanoma may be related to the frequent health checks performed in patients with testicular cancer. Patients who had received extended radiotherapy were also at an increased risk of developing cancer of the stomach and of the colon. Three cases of acute leukaemia were observed more than 5 years after treatment, all of them in patients who had received abdominal radiotherapy only. It is concluded that patients apparently cured of a testicular cancer have an increased risk of developing a new treatment related non-germ cell malignancy, in particular lung cancer. The application of the extended radiotherapy or the combination of radiotherapy and chemotherapy containing alkylating drugs should be avoided in order to reduce this excess risk.

Full text

PDF
639

Images in this article

640Figure 1
on p.640

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cavenee W. K., Dryja T. P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. 1983 Oct 27-Nov 2Nature. 305(5937):779–784. doi: 10.1038/305779a0. [DOI] [PubMed] [Google Scholar]
  2. Dieckmann K. P., Boeckmann W., Brosig W., Jonas D., Bauer H. W. Bilateral testicular germ cell tumors. Report of nine cases and review of the literature. Cancer. 1986 Mar 15;57(6):1254–1258. doi: 10.1002/1097-0142(19860315)57:6<1254::aid-cncr2820570632>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  3. Fosså S. D., Aass N., Kaalhus O. Testicular cancer in young Norwegians. J Surg Oncol. 1988 Sep;39(1):43–63. doi: 10.1002/jso.2930390110. [DOI] [PubMed] [Google Scholar]
  4. Gedde-Dahl T., Jr, Hannisdal E., Klepp O. H., Grøttum K. A., Waksvik H., Fosså S. D., Stenwig A. E., Brøogger A. Testicular neoplasms occurring in four brothers. A search for a genetic predisposition. Cancer. 1985 May 1;55(9):2005–2009. doi: 10.1002/1097-0142(19850501)55:9<2005::aid-cncr2820550930>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  5. Hansen S. W., Groth S., Daugaard G., Rossing N., Rørth M. Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer. J Clin Oncol. 1988 Nov;6(11):1728–1731. doi: 10.1200/JCO.1988.6.11.1728. [DOI] [PubMed] [Google Scholar]
  6. Hay J. H., Duncan W., Kerr G. R. Subsequent malignancies in patients irradiated for testicular tumours. Br J Radiol. 1984 Jul;57(679):597–602. doi: 10.1259/0007-1285-57-679-597. [DOI] [PubMed] [Google Scholar]
  7. Kaldor J. M., Day N. E., Band P., Choi N. W., Clarke E. A., Coleman M. P., Hakama M., Koch M., Langmark F., Neal F. E. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer. 1987 May 15;39(5):571–585. doi: 10.1002/ijc.2910390506. [DOI] [PubMed] [Google Scholar]
  8. Kato H., Schull W. J. Studies of the mortality of A-bomb survivors. 7. Mortality, 1950-1978: Part I. Cancer mortality. Radiat Res. 1982 May;90(2):395–432. [PubMed] [Google Scholar]
  9. Kleinerman R. A., Liebermann J. V., Li F. P. Second cancer following cancer of the male genital system in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985 Dec;68:139–147. [PubMed] [Google Scholar]
  10. Klepp O., Klepp R., Host H., Asbjornsen G., Talle K., Stenwig A. E. Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actinomycin D and medroxyprogesterone acetate. Cancer. 1977 Aug;40(2):638–646. doi: 10.1002/1097-0142(197708)40:2<638::aid-cncr2820400208>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  11. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LI M. C., WHITMORE W. F., Jr, GOLBEY R., GRABSTALD H. Effects of combined drug therapy on metastatic cancer of the testis. JAMA. 1960 Nov 5;174:1291–1299. doi: 10.1001/jama.1960.03030100059013. [DOI] [PubMed] [Google Scholar]
  13. Lothe R. A., Fosså S. D., Stenwig A. E., Nakamura Y., White R., Børresen A. L., Brøgger A. Loss of 3p or 11p alleles is associated with testicular cancer tumors. Genomics. 1989 Jul;5(1):134–138. doi: 10.1016/0888-7543(89)90097-9. [DOI] [PubMed] [Google Scholar]
  14. Peckham M. J., McElwain T. J., Barrett A., Hendry W. F. Combined management of malignant teratoma of the testis. Lancet. 1979 Aug 11;2(8137):267–270. doi: 10.1016/s0140-6736(79)90288-5. [DOI] [PubMed] [Google Scholar]
  15. Peckham M. Testicular cancer. Acta Oncol. 1988;27(4):439–453. doi: 10.3109/02841868809093570. [DOI] [PubMed] [Google Scholar]
  16. Ponder B. Cancer. Gene losses in human tumours. Nature. 1988 Sep 29;335(6189):400–402. doi: 10.1038/335400a0. [DOI] [PubMed] [Google Scholar]
  17. Redman J. R., Vugrin D., Arlin Z. A., Gee T. S., Kempin S. J., Godbold J. H., Schottenfeld D., Clarkson B. D. Leukemia following treatment of germ cell tumors in men. J Clin Oncol. 1984 Oct;2(10):1080–1087. doi: 10.1200/JCO.1984.2.10.1080. [DOI] [PubMed] [Google Scholar]
  18. Roth B. J., Greist A., Kubilis P. S., Williams S. D., Einhorn L. H. Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up. J Clin Oncol. 1988 Aug;6(8):1239–1247. doi: 10.1200/JCO.1988.6.8.1239. [DOI] [PubMed] [Google Scholar]
  19. Smith P. G., Doll R. Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J (Clin Res Ed) 1982 Feb 13;284(6314):449–460. doi: 10.1136/bmj.284.6314.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Willey J. C., Weston A., Haugen A., Krontiris T., Resau J., McDowell E., Trump B., Harris C. C. DNA restriction fragment length polymorphism analysis of human bronchogenic carcinoma. IARC Sci Publ. 1988;(89):439–450. [PubMed] [Google Scholar]
  21. von der Maase H., Rørth M., Walbom-Jørgensen S., Sørensen B. L., Christophersen I. S., Hald T., Jacobsen G. K., Berthelsen J. G., Skakkebaek N. E. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 1986 Nov 29;293(6559):1398–1401. doi: 10.1136/bmj.293.6559.1398. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES